Contact
searchSearch
HMP Global

Volume 16 - Issue 11 - November, 2004

Case Report
Nickel Allergy and the Amplatzer Septal Occluder
08/01/2008
Harinder Singh, MD; Daniel R. Turner, MD; Thomas Forbes, MD
Transcatheter device closure of atrial septal defect (ASD) is an alternative to surgical closure. Currently, the Amplatzer Septal Occluder (ASO) (AGA Medical Corp, Golden Valley, Minnesota) is the only device approved for ASD closure in the...
Transcatheter device closure of atrial septal defect (ASD) is an alternative to surgical closure. Currently, the Amplatzer Septal Occluder (ASO) (AGA Medical Corp, Golden Valley, Minnesota) is the only device approved for ASD closure in the...
Transcatheter device closure of...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Unprotected Left Main “Kissing” Stent Implantation With a Percutaneous Ventricular Assist Device
08/01/2008
Srihari S. Naidu, MD; Howard C. Herrmann, MD; Ruchira Glaser, MD, MSCE; Sameer Rohatgi, MD
Case Report. An 80-year-old man with severe chronic obstructive pulmonary disease, chronic renal insufficiency and significant carotid artery disease presented with a 4-day history of episodic severe substernal chest pressure at rest....
Case Report. An 80-year-old man with severe chronic obstructive pulmonary disease, chronic renal insufficiency and significant carotid artery disease presented with a 4-day history of episodic severe substernal chest pressure at rest....
Case Report. An 80-year-old man...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
Editor`s Message (Nov. 2004)
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of The Journal of Invasive Cardiology, which coincides with the American Heart Association Annual Scientific Sessions, includes original research articles, case reports, reviews, and articles from the journal’s...
Dear Readers, This issue of The Journal of Invasive Cardiology, which coincides with the American Heart Association Annual Scientific Sessions, includes original research articles, case reports, reviews, and articles from the journal’s...
Dear Readers, This issue of The...
08/01/2008
Journal of Invasive Cardiology
Case Report
Transcatheter Treatment of Lutembacher Syndrome: Combined Balloon Mitral Valvuloplasty and Percutaneous Atrial Septal Defect Cl
08/01/2008
Mariano Ledesma, MD; Patricio Martinez, MD; Miguel Angel Cazares, MD; Ted Feldman, MD, FSCAI, FACC, FESC
Lutembacher syndrome is a rare combination of congenital ASD and acquired rheumatic mitral stenosis. It is usually treated by surgical correction. We describe a case of Lutembacher syndrome that was treated successfully with percutaneous...
Lutembacher syndrome is a rare combination of congenital ASD and acquired rheumatic mitral stenosis. It is usually treated by surgical correction. We describe a case of Lutembacher syndrome that was treated successfully with percutaneous...
Lutembacher syndrome is a rare...
08/01/2008
Journal of Invasive Cardiology
Case Report
Diffuse Saphenous Vein Graft Spasm
08/01/2008
Vaishali Ashar, MBBS; Giampaolo Niccoli, MD, PhD; Italo Porto, MD, PhD
Case Report. A 53-year-old man presented with a history of angina at rest, a small troponin rise and ischaemic inferior ECG changes. He had undergone aortocoronary bypass operation for triple vessel disease 3 years before this admission. The...
Case Report. A 53-year-old man presented with a history of angina at rest, a small troponin rise and ischaemic inferior ECG changes. He had undergone aortocoronary bypass operation for triple vessel disease 3 years before this admission. The...
Case Report. A 53-year-old man...
08/01/2008
Journal of Invasive Cardiology
Case Report
Advanced Atheroscrelotic Plaque as a Potential Cause of No-reflow in Elective Percutaneous Coronary Intervention — Intravascular
08/01/2008
Shigenori Ito, MD; Masanao Saio, MD; Takahiko Suzuki, MD
No-reflow sometimes occurs in percutaneous coronary intervention (PCI) as a terrible complication with an incidence of 2–5%.1,2 No-reflow has been reported to be related to the presence of thrombus, lipid pool (vulnerable plaque), and other...
No-reflow sometimes occurs in percutaneous coronary intervention (PCI) as a terrible complication with an incidence of 2–5%.1,2 No-reflow has been reported to be related to the presence of thrombus, lipid pool (vulnerable plaque), and other...
No-reflow sometimes occurs in...
08/01/2008
Journal of Invasive Cardiology
Case Report
Successful Revascularization of a Long Chronic Total Occlusion With Blunt Microdissection Complicated by Coronary Artery Dissect
08/01/2008
Jeffrey D. Lorin, MD; Jason R. Boglioli, MD; Steven P. Sedlis, MD
Percutaneous revascularization of chronic total occlusions (CTOs) represents an important clinical challenge in interventional cardiology. A CTO is defined as, “an obstruction of a native coronary artery for greater than 30 days with no...
Percutaneous revascularization of chronic total occlusions (CTOs) represents an important clinical challenge in interventional cardiology. A CTO is defined as, “an obstruction of a native coronary artery for greater than 30 days with no...
Percutaneous revascularization...
08/01/2008
Journal of Invasive Cardiology
Commentary
Primary PCI Without On-site Surgery and Without On-site
Cath Lab
08/01/2008
Ubeydullah Deligonul, MD
Modern treatment of acute myocardial infarction is based on early and complete reperfusion. The time between the onset of myocardial infarction and reperfusion determines the mortality benefit and is influenced by various factors including a...
Modern treatment of acute myocardial infarction is based on early and complete reperfusion. The time between the onset of myocardial infarction and reperfusion determines the mortality benefit and is influenced by various factors including a...
Modern treatment of acute...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Adjunctive Therapy for Cardiovascular Intervention — Its Time Has Come
08/01/2008
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
It is with great excitement that The Journal of Invasive Cardiology will be initiating a new section called “Adjunctive Therapy.” While much of the focus of cardiovascular intervention relies upon mechanical approaches to improve perfusion,...
It is with great excitement that The Journal of Invasive Cardiology will be initiating a new section called “Adjunctive Therapy.” While much of the focus of cardiovascular intervention relies upon mechanical approaches to improve perfusion,...
It is with great excitement that...
08/01/2008
Journal of Invasive Cardiology
The Angiomax Peripheral Procedure Registry of Vascular Events Trial (APPROVE): In-Hospital and 30-Day Results
08/01/2008
David E. Allie, MD; John J. Young, MD; John R. Laird, MD, FACC, FACP; Patrick Hall, MD; Nicolas W. Shammas, MD, MS, FACC, FSCAI, FACP, FSVM; Robert Safian, MD; Ajay Virmani, MD
Peripheral arterial disease (PAD) affects 8–12 million Americans with an estimated 12–20% of the population > 65 years of age afflicted. Approximately 50% of patients are asymptomatic, which may explain why this disease is often...
Peripheral arterial disease (PAD) affects 8–12 million Americans with an estimated 12–20% of the population > 65 years of age afflicted. Approximately 50% of patients are asymptomatic, which may explain why this disease is often...
Peripheral arterial disease...
08/01/2008
Journal of Invasive Cardiology
Electrophysiology Corner
Acute Right Coronary Artery Occlusion in an Adult Patient After Radiofrequency Catheter Ablation of a Posteroseptal Accessory Pa
08/01/2008
Peter Y. Hui, MD; Truong Duong, MD; James Mailhot, MD
Radiofrequency catheter ablation (RFCA) of accessory pathways (APs) is recommended as definitive therapy for symptomatic or life-threatening tachyarrhythmias associated with the Wolff-Parkinson-White (WPW) syndrome. Although various...
Radiofrequency catheter ablation (RFCA) of accessory pathways (APs) is recommended as definitive therapy for symptomatic or life-threatening tachyarrhythmias associated with the Wolff-Parkinson-White (WPW) syndrome. Although various...
Radiofrequency catheter ablation...
08/01/2008
Journal of Invasive Cardiology
Case Report
Reversible Pulmonary Hypertension in a Patient Treated
with Protacylcin
08/01/2008
Heide Johnson, RN; Dean J. Kereiakes, MD, FACC, MSCAI; Peter J. Engel, MD; Robert Baughman, MD
Untreated pulmonary hypertension is a relentlessly progressive disorder leading to death from right ventricular failure, regardless of etiology. In recent years, more effective medical therapy has become available for this condition. In...
Untreated pulmonary hypertension is a relentlessly progressive disorder leading to death from right ventricular failure, regardless of etiology. In recent years, more effective medical therapy has become available for this condition. In...
Untreated pulmonary hypertension...
08/01/2008
Journal of Invasive Cardiology
Case Report
The Novel Use of a Covered Stent in the Management of a Left Internal Mammary Artery to Pulmonary Vasculature Fistula
08/01/2008
Benedict M. Glover, MD, MRCP; Mazhar M. Khan, FRCP
Left internal mammary artery (LIMA) to pulmonary vasculature fistulas are rare complications following coronary artery bypass surgery. In symptomatic cases, management tends to be either conservative or surgical ligation of the fistula. This...
Left internal mammary artery (LIMA) to pulmonary vasculature fistulas are rare complications following coronary artery bypass surgery. In symptomatic cases, management tends to be either conservative or surgical ligation of the fistula. This...
Left internal mammary artery...
08/01/2008
Journal of Invasive Cardiology
Case Report
Distal Protection of the Left Anterior Descending Artery with the EX Filter Wire During an Acute Coronary Syndrome
08/01/2008
Ashish Pershad, MD; Jon Stevenson, MD
Distal coronary embolization is an unpredictable complication of percutaneous coronary intervention (PCI). No reflow, distal coronary occlusion and peri-procedural cardiac enzyme elevation (“infarctlets”) may result from distal embolization....
Distal coronary embolization is an unpredictable complication of percutaneous coronary intervention (PCI). No reflow, distal coronary occlusion and peri-procedural cardiac enzyme elevation (“infarctlets”) may result from distal embolization....
Distal coronary embolization is...
08/01/2008
Journal of Invasive Cardiology
Six-Month Clinical and Angiographic Outcomes of the Tecnic Carbostent‚Ñ¢Coronary System: The Phantom IV Study
08/01/2008
Angela Migliorini, MD; David Antoniucci, MD; Gian B. Danzi, MD; Cinzia Capuano, MD; Marco Sesana, MD; Roberto Baglini, MD, PhD; Antonio L. Bartorelli, MD; Daniela Trabattoni, MD
The Tecnic Carbostent™ (Sorin Biomedica, Saluggia, Italy) is a balloon-expandable, stainless steel tubular coronary stent with a unique cellular design and proprietary Carbofilm™ permanent coating.1-3 Recently the stent has been pre-mounted...
The Tecnic Carbostent™ (Sorin Biomedica, Saluggia, Italy) is a balloon-expandable, stainless steel tubular coronary stent with a unique cellular design and proprietary Carbofilm™ permanent coating.1-3 Recently the stent has been pre-mounted...
The Tecnic Carbostent™ (Sorin...
08/01/2008
Journal of Invasive Cardiology
Primary Angioplasty Without On-site Surgical Back-up: The First Experience with Mobile Catherization Facility
08/01/2008
Ramazan Akdemir, MD; Hakan Ozhan, MD; Enver Erbilen, MD; Mehmet Yazici, MD; Sinan Albayrak, MD; Huseyin Gunduz, MD; Cihangir Uyan, MD
Multi-center randomized trials indicate that primary angioplasty in acute myocardial infarction (AMI) lowers the rates of death, stroke, recurrent ischemia and re-infarction compared with fibrinolytic therapy.1 For low-risk patients with AMI,...
Multi-center randomized trials indicate that primary angioplasty in acute myocardial infarction (AMI) lowers the rates of death, stroke, recurrent ischemia and re-infarction compared with fibrinolytic therapy.1 For low-risk patients with AMI,...
Multi-center randomized trials...
08/01/2008
Journal of Invasive Cardiology
Superior In-Hospital and 30-Day Outcomes with Abciximab Versus Eptifibatide: A Contemporary Analysis of 495 Consecutive Percutan
08/01/2008
Robert J. Applegate, MD; Sanjay K. Gandhi, MD, PhD; Michael A. Kutcher, MD, FACC, FSCAI; Bharathi Upadhya, MD; David C. Sane, MD; Efthymios N. Deliargyris, MD
Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...
Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...
Over the past decade clinical...
08/01/2008
Journal of Invasive Cardiology
Coronary Pressure Notch: An Early Non-hyperemic Visual Indicator of the Physiologic Significance of a Coronary Artery Stenosis
08/01/2008
Morton J. Kern, MD, MSCAI, FACC, FAHA; David R. Holmes, Jr., MD; Priya Velappan, MD
The limitations of coronary angiography for defining the functional significance of intermediately severe lesions are well known. Such angiographic presentations frequently require additional testing to determine their clinical relevance....
The limitations of coronary angiography for defining the functional significance of intermediately severe lesions are well known. Such angiographic presentations frequently require additional testing to determine their clinical relevance....
The limitations of coronary...
08/01/2008
Journal of Invasive Cardiology
Primary Angioplasty of Unprotected Left Main Coronary Artery
for Acute Anterolateral Myocardial Infarction
08/01/2008
Yoshihisa Nakagawa, MD; Takeshi Kimura, MD; Masakiyo Nobuyoshi, MD; Hideyuki Nosaka, MD; Katsumi Inoue, MD; Masashi Iwabuchi, MD; Hiroyoshi Yokoi, MD; Kenji Ando, MD; Koyu Sakai, MD
Despite the advancements in acute myocardial infarction (AMI) treatment, AMI caused by acute unprotected left main coronary artery (LMCA) occlusion rapidly progresses to cardiogenic shock and death unless there are substantial preexisting...
Despite the advancements in acute myocardial infarction (AMI) treatment, AMI caused by acute unprotected left main coronary artery (LMCA) occlusion rapidly progresses to cardiogenic shock and death unless there are substantial preexisting...
Despite the advancements in...
08/01/2008
Journal of Invasive Cardiology
Commentary
PCI for Acute Myocardial Infarction Caused by Left Main Disease
08/01/2008
On Topaz, MD, FACC
Percutaneous revascularization of left main coronary lesions is a hot topic. During the recent TCT conference, multiple live cases and discussions were dedicated to new advancements in the treatment of left main disease. The high level of...
Percutaneous revascularization of left main coronary lesions is a hot topic. During the recent TCT conference, multiple live cases and discussions were dedicated to new advancements in the treatment of left main disease. The high level of...
Percutaneous revascularization...
08/01/2008
Journal of Invasive Cardiology
Predictors of Survival After Contemporary Percutaneous Coronary Revascularization for Acute Myocardial Infarction in the Real Wo
08/01/2008
Pieter C. Smits, MD, PhD; Willem J. van der Giessen, MD, PhD; Pim J. de Feyter, MD, PhD; Ron T. van Domburg, PhD; Kengo Tanabe, MD; Chi-Hang Lee, MD, MBBS, MRCP; Angela Hoye, MB, MRCP, MD, MBChB; Pedro A. Lemos, MD; Patrick W. Serruys, MD, PhD
Management strategies for ST-elevation myocardial infarction (STEMI) have undergone great evolution over the past decade. Currently, primary mechanical reperfusion is considered superior to thrombolytic therapy in achieving complete and...
Management strategies for ST-elevation myocardial infarction (STEMI) have undergone great evolution over the past decade. Currently, primary mechanical reperfusion is considered superior to thrombolytic therapy in achieving complete and...
Management strategies for...
08/01/2008
Journal of Invasive Cardiology
Bacteremia Following Complex Percutaneous Coronary Intervention
08/01/2008
Nick Newall, MRCP; David R. Ramsdale, FRCP, MD, BSc, MBChB; Shahid Aziz, BSc, MD, MRCP, MBChB; Mark Jackson, PhD; Nick D. Palmer, MD, MRCP, MBBS, FRCP
Bacteremic complications after cardiac catheterization and percutaneous coronary intervention are perhaps surprisingly rare considering the frequency of entry into the circulation of arterial sheaths, guide catheters, guidewires, balloon...
Bacteremic complications after cardiac catheterization and percutaneous coronary intervention are perhaps surprisingly rare considering the frequency of entry into the circulation of arterial sheaths, guide catheters, guidewires, balloon...
Bacteremic complications after...
08/01/2008
Journal of Invasive Cardiology
Vasoreactivity of the Radial Artery After Transradial Catheterization
08/01/2008
Javier Goicolea, MD; Francesco Calvo; Marcelo Sanmartin, MD; Raymundo Ocaranza, MD; Diogenes Cuevas, MD
The radial artery provides a safer alternative for left heart catheterization compared to femoral or brachial arteries, and also allows early mobilization without the need for closure devices.1 However, due to the similar dimensions of radial...
The radial artery provides a safer alternative for left heart catheterization compared to femoral or brachial arteries, and also allows early mobilization without the need for closure devices.1 However, due to the similar dimensions of radial...
The radial artery provides a...
08/01/2008
Journal of Invasive Cardiology
Commentary
Transradial Catheterization: The Road Less Traveled
08/01/2008
Nitin Barman, MD; John H. Chiu, MD; Stephen G. Ellis, MD
Retrograde cannulation of a peripheral artery is a necessary step for current percutaneous coronary procedures. Since the first reported case of coronary angiography via the radial artery by Campeau in 1989, the transradial approach has been...
Retrograde cannulation of a peripheral artery is a necessary step for current percutaneous coronary procedures. Since the first reported case of coronary angiography via the radial artery by Campeau in 1989, the transradial approach has been...
Retrograde cannulation of a...
08/01/2008
Journal of Invasive Cardiology

News

thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
AI Cardiac Imaging Software
Study Reveals Stark Disconnect Between Americans’ Desire for Preventive Cardiac Screening and Care They Can Access
01/27/2026
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to...
01/27/2026
Cath Lab Digest
Patent Foramen Ovale Detection
BURL Concepts Announces First Human Uses of FOQUS Ultrasound System for Patent Foramen Ovale (PFO) Detection
01/27/2026
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system,...
01/27/2026
Cath Lab Digest
AI Plaque analysis
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
01/21/2026
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER,...
01/21/2026
Cath Lab Digest
AI Plaque analysis
Coverage Unlocks Reimbursable AI Plaque Quantification With Circle Cardiovascular Imaging's cvi42|Plaque
01/21/2026
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle...
01/21/2026
Cath Lab Digest
Acquisitions
Haemonetics Acquires Vivasure Medical Limited
01/21/2026
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite...
01/21/2026
Cath Lab Digest
Early CAD Detection
Mammograms and Hidden Heart Disease: Annual Scans Can Detect This Silent Killer and Help Save Lives, but Awareness Is Key
01/21/2026
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast...
01/21/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Demonstrates Ability to Offer Interventional Physicians Unmatched Level of Radiation Protection Thanks to First-of-Its-Kind NOVARAD Clinical Study
01/21/2026
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD...
01/21/2026
Cath Lab Digest
Technology & Health Literacy
ECRI: Misuse of AI Chatbots Tops Annual List of Health Tech Hazards
01/21/2026
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots...
01/21/2026
Cath Lab Digest
CAD Risk Factors
North Carolina State University Study Finds Police-Related Stress Associated With Physical Markers of Cardiovascular Health Risk for Black Women
01/19/2026
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related...
01/19/2026
Cath Lab Digest

Bangalore top 10
Author Interview
Editor’s 2025 Top 10: Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease
02/02/2026
Sripal Bangalore, MD, MHA; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Editor's 2025 Top 10
Editor's Message
Editor’s 2025 Top 10
02/02/2026
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Original Contribution
Early Outcomes of the Myval Octacor Transcatheter Heart Valve in Transcatheter Aortic Valve Implantation: A Single-Center Study From Serbia
01/30/2026
Valentina Balint, MD; Mihajlo Farkic, MD; Jovan Petrovic, MD; Matija Furtula, MD; Milos D. Babic, MD; Dragan Topic, MD; Ida Subotic, MD; Vladimir Zobenica, MD; Alfonso Ielasi, MD; Luca Testa, MD, PhD; Milovan Bojic, MD, PhD; Aleksandra Nikolic, MD, PhD
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early...
01/30/2026
Journal of Invasive Cardiology
Sovari Figure 1
Clinical Videos
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a...
01/28/2026
Journal of Invasive Cardiology
Bradt Figure
Clinical Videos
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal...
01/28/2026
Journal of Invasive Cardiology
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
Heart Failure Devices
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
01/27/2026
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected...
01/27/2026
Cath Lab Digest
HighLife TMVR
Mitral Valve Intervention
HighLife Receives CE Mark Approval for its Transcatheter Mitral Valve Replacement (TMVR) Solution
01/27/2026
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a...
01/27/2026
Cath Lab Digest

November 2004 Volume 16 Issue 11

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use